JM

Juan-pablo Mas

Partner at Action Potential Investor

San Francisco Bay Area

Overview 

Juan-Pablo Mas is a Partner at Action Potential VC in the San Francisco Bay Area, with a strong background in venture capital, product management, and entrepreneurship. His career highlights include serving on the boards of several successful medical device companies and making strategic investments in companies like Presidio Medical and Exo Imaging. Mas holds an MBA from Stanford University Graduate School of Business and has invested in companies at various stages, focusing on sectors such as Medical Devices, Pharmaceuticals, and Digital Health.

Work Experience 

AP

Action Potential Venture Capital

  • Partner

    2014 - Current

    Investing in the next generation of Bioelectronic Medicines, Precision Diagnostics (AI), and Computational Biology. www.actionpotentialvc.com Board Member at Onc.AI, Exo Imaging, Saluda Medical, SetPoint Medical, Presidio Medical, and Cala Health.

O

Onc.AI

  • Board Member

    2022

    Onc.AI is developing a multimodal AI/ML radiomics platform, to support oncologists in personalized therapeutic decision-making for patients across cancer types.

Onc.AI is a software that specializes in clinical oncology, genomics, proteomics, and radiomics.

Raised $33,000,000.00 from National Cancer Institute.

onc.ai
EI

Exo Imaging, Inc.

  • Board Member

    2020

SM

Saluda Medical

  • Board Member

    2017

PM

Presidio Medical, Inc.

  • Board Member

    2018

Presidio Medical is a medtech company that develops a transformational neuromodulation platform.

Raised $102,000,000.00 from Invus Opportunities, Shangbay Capital, Deerfield and Action Potential Venture Capital.

presidiomedical.com
SM

SetPoint Medical

  • Board Member

    2014

SetPoint Medical develops novel therapeutics for the treatment of chronic autoimmune conditions.

Raised $344,000,000.00 from Citta Capital, SVE Capital, Shangbay Capital, Gilmartin Capital LLC, New Enterprise Associates, Boston Scientific, Action Potential Venture Capital, Richard King Mellon Foundation and Euclidean Capital.

setpointmedical.com
GD

Gradient Denervation Technologies

  • Board Member

    2020

NM

Neuspera Medical Inc.

  • Board Observer

    2016

NeuSpera Medical is a manufacturing firm that designs, manufactures, and sells implantable neuromodulation medical devices.

Raised $134,888,888.00 from Action Potential Venture Capital, Treo Ventures, Windham Venture Partners, Vertex Ventures HC and Olympus.

neuspera.com
CH

Cala Health

  • Board Member

    2023

  • Board Observer

    2016 - 2023

Cala Health is a bioelectronic medicine company that provides medical devices and neurotherapeutics for managing chronic health conditions.

Raised $198,300,000.00 from Johnson & Johnson Innovation – JJDC, Lightstone Ventures, Nexus NeuroTech, Reimagined Ventures, Fiscus Ventures, Lux Capital, Action Potential Venture Capital, Ascension Ventures, OSF Ventures and Google Ventures.

calahealth.com
WT

Wu Tsai Neurosciences Institute

  • Stanford Wu Tsai Neurosciences Institute: Translational Oversight Committee

    2018

Education 

Investments 

Presidio Medical

Series A

Total funding: $100M

Saluda Medical

Series D

Total funding: $190M

SetPoint Medical

Series C

Total funding: $300M

Onc.AI

Series A

Total funding: $31M

Articles About Juan-pablo

Relevant Websites